Rhythm cuts MC4R royalty rate to 1% in amended LG Chem deal
AI Summary- Rhythm amended its global bivamelagon license agreement with LG Chem.
- $350 million in fixed payments will be made through September 2029.
- Rhythm announced a five-year facility with up to $750 million available.